To date, vaccines against COVID-19 have continued to offer some protection against variants. But a vaccine-resistant strain could develop in the future. Dr. Mark Dybul, CEO of Enochian Biosciences, joins CBSN’s “Red & Blue” anchor Elaine Quijano to discuss the risk, as well as the latest data on the Pfizer antiviral pill.
Add Comment